Ładuje się......
A meta-analysis on the efficacy and tolerability of natalizumab in relapsing multiple sclerosis
INTRODUCTION: Natalizumab is a new humanized monoclonal antibody used in multiple sclerosis (MS). The aim of this meta-analysis was to evaluate the efficacy and tolerability of this drug in relapsing MS. PubMed, Scopus, Web of Science, and Cochrane Central Register of Controlled Trials were searched...
Zapisane w:
| Główni autorzy: | , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Termedia Publishing House
2010
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3281346/ https://ncbi.nlm.nih.gov/pubmed/22371753 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/aoms.2010.13901 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|